Gut Bacteria and Chemicals Differ in Mild Cognitive Impairment, Small Study Finds

The work was published in the journal MedComm in 2026. It is an observational study in people, so it can show links but not causes. Researchers analysed fecal samples from 35 older adults: 18 with mild cognitive impairment (MCI) and 17 cognitively healthy controls. According to Medical Xpress, the team came from Cardiff University and Imperial College London.

MCI means thinking skills have slipped more than expected for age, but daily life is not yet affected and the person does not meet the criteria for dementia. The paper notes that people with MCI develop Alzheimer's disease at roughly 10% to 15% a year, against 1% to 2% for cognitively normal older adults. Doctors cannot easily tell who will worsen quickly. Current tools such as long cognitive tests, brain scans and spinal fluid tests are slow, costly or invasive. A simple stool test would be a real change if it worked. If gut differences prove inconsistent from group to group, as the authors say earlier studies have been, no such test is likely.

The design was careful in one respect. Sixteen of the pairs were couples living together, one with MCI and one without, which reduces the effect of shared diet and home environment. The groups were well matched for age, sex, education and body mass index. They differed, as expected, in scores on the Montreal Cognitive Assessment, a memory and thinking screen (20.3 in the MCI group, 27.4 in controls).

Overall microbial diversity did not differ between the groups. Four of 138 bacterial groups did. After accounting for the couples, Izemoplasmatales was more abundant in people with MCI. Lachnospira, Lachnospiraceae UCG-008 and Ruminococcus were less abundant. The authors dropped UCG-008 from their models because most samples contained none of it. Using the other three, the best of five machinelearning models separated MCI from controls with an AUC of 0.972. The average across models was 0.900. An AUC of 1.0 is perfect and 0.5 is a coin flip. These figures come from the same small group the models learned from, so they are likely to look better than real-world performance.

Two stool chemicals also differed. Proline was higher in people with MCI and fumaric acid was lower. Proline was higher in the partner with MCI in 12 of 16 couples, and fumaric acid was lower in 11 of 16. Models using these two chemicals reached AUCs between 0.81 and 0.92.

The authors tested the bacterial signature in a separate group of 30 people with MCI and 30 controls from another study. Izemoplasmatales was absent there, so only two bacteria could be used. They gave an AUC of 0.825, with a wide 95% confidence interval of 0.605 to 1.0. Lachnospira was lower in MCI, matching the main group. Ruminococcus, however, was reported as higher in MCI in the second group. That is the opposite direction to the main group, where it was lower, even though the paper describes the results as consistent. This is the kind of inconsistency the authors say has held the field back.

The prediction question is the one that matters most for personal health, and it rests on the thinnest data. Seventeen people with MCI completed a 12-month follow-up. They were ranked by how much their cognition declined and grouped as rapid decliners (6 people) or slow decliners (6 people). With groups that small, any link between starting gut profile and later decline is preliminary. We could not confirm from the press coverage which specific bacteria or chemicals, if any, were tied to faster decline, so we do not draw that conclusion here.

The study does not show that gut bacteria cause or prevent memory loss. It does not show that changing the gut would slow decline. It is not a validated test. Everyone was White, and the sample was small. The paper itself notes that longitudinal studies of this kind are rare, and our view is that larger ones are needed.

This adds a different angle to the paper's October 6 report on a gut bacterial molecule called ImP, which was linked to Alzheimer's brain changes in a separate University of Wisconsin-Madison study. That work centred on one molecule measured in blood. This one profiles stool bacteria and chemicals. Both point to the gut as a place to look for early signals, but neither is a test yet.

What to watch next

What to watch next is whether larger, more varied groups followed over time can reproduce these bacteria and chemicals, and whether they predict decline better than the cognitive tests and blood markers already available.

Removing Brain Immune Cells Restored Two Hours of Sleep in Alzheimer's Mice Gut Bacteria and Chemicals Differ in Mild Cognitive Impairment, Small Study Finds Starting Statins Soon After Diabetes Diagnosis Linked to Less Dementia Flavourings, Colourings and Sweeteners Linked to Higher Depression Risk Older Adults on Self-Chosen Vegan Diet Lost Leg Muscle in 12 Weeks Topical Vitamin K2 Cream Improved Wrinkles and Firmness in Small Trial Staying Active Over Years Linked to 44% Lower Frailty Risk East Germans Who Faced Covert State Repression Still Report More Stress Four Cardio Styles Compared: High-Intensity Intervals Beat Moderate Intervals on Fitness AI Predicted Brain Amyloid From Blood Tests, but Faltered on New Patients Boosting Gene ZNF865 With CRISPR Reversed Aging Signs in Degenerated Spinal Disc Cells Review of 26 Cohorts Links Time-Restricted Eating to Better Blood Sugar Years of Fitbit Data Link Steady Daily Rhythms to Slower Biological Aging Review of Nine Meta-Analyses Links Hearing Loss to 43% Higher Dementia Odds UK Biobank Study of 170,000 Women Links HRT to Higher Cardiovascular Risk Small Trial Finds Ultra-Processing Alone Did Not Change Short-Term Satiety Combining Cardio and Strength Training Beats Cardio Alone in Heart Rehab 20-Gram Protein Dose Failed to Boost Muscle Building in Older Men Mediterranean Diet Linked to Slightly Younger DNA-Based Aging Readings in Study Gut Microbes May Shape How Environmental Toxicants Affect the Brain, Review Says Review Says Simply Raising NAD+ or SIRT1 May Not Slow Ageing Review Calls Chronic Stress Before Surgery a Possible Modifiable Heart Risk Review Maps How CRISPR Delivery Could Target Aging's Hallmarks Deep Learning Model Melody Reads DNA Code to Predict Methylation Patterns Mostly-Easy Polarized Training Beat Threshold Workouts on Endurance Markers, Not VO2max Trump Executive Order Creates New NIH Division and Task Force on Women's Health Review of 46 Studies Finds Ultra-Processed Food Heart Research Methodologically Weak Review Finds No Consistent Epigenetic Age Reversal From Antioxidant Supplements Time-Restricted Eating Raises Ketones, Modestly Calms Inflammation, Review Finds Gut-Made Short-Chain Fatty Acids Linked to Brain Protection in Low Blood Flow